Lamictal XR 300 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FQYXK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,382
Award facts
- Contract value 100% obligated
- $4,382.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lamictal XR 300 mg tablets (30-count units) under a firm fixed-price contract on July 2, 2025, with a ceiling value of $4,382.36 and an ultimate completion date of July 3, 2025. This award represents a non-competitive set-aside delivery order issued from AmerisourceBergen's existing DLA contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems, with the place of performance located at their corporate office in Conshohocken, PA.
This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.999 billion value through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. Lamictal XR (lamotrigine extended-release), a neurological treatment used for seizure management and mood disorders, falls within the company's established portfolio of specialty medications delivered through this strategic contract relationship with the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQYXK?
SPE2DB25FQYXK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 2, 2025.
How much is contract SPE2DB25FQYXK worth?
The government has obligated $4,382 on SPE2DB25FQYXK.
Is contract SPE2DB25FQYXK an order under another contract?
Yes. SPE2DB25FQYXK is a delivery order under SPE2DB25D3021, an indefinite delivery contract.
Was contract SPE2DB25FQYXK competed?
The extent of competition for SPE2DB25FQYXK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award